Krieger Nancy 4
4 · Talaris Therapeutics, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
Krieger Nancy
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+190,000→ 190,000 totalExercise: $9.10Exp: 2032-01-31→ Common Stock (190,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest as follows: 25% shall vest on February 1, 2023; and the remaining shall vest in 36 equal monthly installments thereafter.